Sajeel Chowdhary, MD
Basic profileSajeel Chowdhary is a Neurology physician affiliated with Tampa General Hospital. OpenAlex indexes 82 publications with 1,336 citations (h-index 18); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Day One BiopharmaceuticalsProgram year20252 payments$3,528
- CATALYST PHARMACEUTICALS, INC.Program year20252 payments$2,367
- Telix PharmaceuticalsProgram year202510 payments$1,719
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
82%Other antiepileptics32.7%Levetiracetam78%Lacosamide22%Part D<11 patientsN-methyl-D-aspartate Receptor Antagonist12.3%Memantine Hcl100%Part D≥11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
10%Serotonin-3 Receptor Antagonist10%Ondansetron Hcl100%Part D≥13 patientsSensory organs
8.1%Corticosteroid8.1%Dexamethasone100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Samip Vasaiwala, MD
Tampa General Hospital
Rodney Landreneau, MD
Tampa General Hospital
Hiram Bezerra, MD
Tampa General Hospital
Mayer Fishman, MD
Tampa General Hospital
Bruce Miller, MD
University of California, San Francisco (UCSF)
David Knopman, MD
Mayo Clinic Rochester
Brett Kissela, MD
Medical College of Wisconsin
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”